Bank Of New York Mellon Corp Sorrento Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $1.14 Million - $2.82 Million	1,538,421 New	1,538,421 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $159,297 - $303,825	105,495 Added 8.72%	1,314,634 $2.06 Million
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $277,309 - $521,074	223,637 Added 22.69%	1,209,139 $2.43 Million
Q1 2022 May 11, 2022	BUY	$2.0 - $4.9 $54,482 - $133,480	27,241 Added 2.84%	985,502 $2.3 Million
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.23 $949,176 - $1.48 Million	-204,124 Reduced 17.56%	958,261 $4.46 Million
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $1.11 Million - $1.64 Million	149,208 Added 14.73%	1,162,385 $8.87 Million
Q2 2021 Aug 11, 2021	BUY	$6.35 - $10.0 $666,280 - $1.05 Million	104,926 Added 11.55%	1,013,177 $9.82 Million
Q1 2021 May 13, 2021	SELL	$7.03 - $16.51 $141,844 - $333,122	-20,177 Reduced 2.17%	908,251 $7.51 Million
Q4 2020 Feb 09, 2021	BUY	$5.76 - $11.95 $996,422 - $2.07 Million	172,990 Added 22.9%	928,428 $6.34 Million
Q3 2020 Nov 12, 2020	BUY	$6.17 - $18.82 $670,888 - $2.05 Million	108,734 Added 16.81%	755,438 $8.42 Million
Q2 2020 Aug 12, 2020	BUY	$1.73 - $6.76 $405,870 - $1.59 Million	234,607 Added 56.93%	646,704 $4.06 Million
Q1 2020 May 06, 2020	BUY	$1.57 - $4.76 $11,983 - $36,333	7,633 Added 1.89%	412,097 $758,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $40,692 - $117,026	-28,064 Reduced 6.49%	404,464 $1.37 Million
Q3 2019 Nov 07, 2019	SELL	$2.05 - $2.69 $42,084 - $55,223	-20,529 Reduced 4.53%	432,528 $925,000
Q2 2019 Aug 12, 2019	BUY	$2.67 - $4.38 $45,139 - $74,048	16,906 Added 3.88%	453,057 $1.21 Million
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $25,482 - $81,378	13,700 Added 3.24%	436,151 $2.07 Million
Q4 2018 Feb 11, 2019	BUY	$2.01 - $4.24 $50,420 - $106,360	25,085 Added 6.31%	422,451 $1.01 Million
Q3 2018 Nov 09, 2018	BUY	$4.22 - $7.5 $358,476 - $637,102	84,947 Added 27.19%	397,366 $0
Q2 2018 Aug 06, 2018	BUY	$4.75 - $8.0 $1.2 Million - $2.03 Million	253,360 Added 428.99%	312,419 $2.25 Million
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $20,074 - $44,386	4,461 Added 8.17%	59,059 $305,000
Q4 2017 Feb 09, 2018	BUY	$1.75 - $3.8 $95,546 - $207,472	54,598	54,598 $207,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account